Press releases

Month Year

Email alerts

Mar 30, 2014

Medtronic Global SYMPLICITY Registry Shows Strong Safety Profile of the Symplicity(TM) Renal Denervation System

Six-Month Analysis of First 1,000 Patients Enrolled in Real-World Patient Registry Presented at ACC.14

MINNEAPOLIS and WASHINGTON, D.C. - March 30, 2014 - Medtronic, Inc. (NYSE: MDT), announced today further analysis of six-month follow-up data from the first 1,000 patients enrolled in the Global...
Mar 30, 2014

World's First Transcatheter Valve, Medtronic Melody® Transcatheter Pulmonary Valve Shows Positive Clinical Outcomes in Real-World Study

Has Repaired Hearts of 6,000+ Patients; More Than Half Are Children

MINNEAPOLIS and WASHINGTON - March 30, 2014 - Medtronic, Inc. (NYSE: MDT), today announced the one-year results of the Melody® Transcatheter Pulmonary Valve (TPV) U.S. Post-Approval Study, which...
Mar 29, 2014

Medtronic CoreValve® System Results Superior to Open-Heart Surgery at One Year in U.S. Pivotal Trial

CoreValve High Risk Study: FDA Determines Expert Panel Not Required

MINNEAPOLIS and WASHINGTON - March 29, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that the CoreValve® System showed results superior to surgical aortic valve replacement (SAVR) at one...
Mar 29, 2014

Medtronic Releases Results of SYMPLICITY HTN-3

Medtronic Commits to Further Clinical Investigation and Determining Path Forward for Next U.S. IDE with FDA

MINNEAPOLIS and WASHINGTON, DC - March 29, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the full results of the SYMPLICITY HTN-3 clinical trial, which were presented today in late-breaking...
Mar 28, 2014

AORN Foundation, Covidien Team to Offer New Tools for Emerging Nurse Leaders

DENVER, Colo. and DUBLIN, Ireland – March 28, 2014 – In a move aimed at giving nursing professionals the tools they need to address rapidly changing practices and cost structures, the AORN...

Show per page